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Human immunodeficiency virus (HIV) was purified by sucrose gradient centrifugation and labeled with octadecylrhod- 
amine B-chloride (R- 18) under conditions resulting in 90% quenching of the fluorescence label. Incubation of R- 1 I-labeled 
HIV (R-IS/HIV) with CD4-positive CEM and HUT-102 cells, but not with CD4-negative MLA-144 cells, resulted in 
fluorescence dequenching (DQ, increase in fluorescence) of 2&25%. Similar level of DQ was observed upon incubation 
of CEM cells with R-IS-labeled Sendai virus. DQ was observed when R-18/HIV was incubated with CD4+ cells at 37”C, 
but not at 4°C. Most of the increase in fluorescence occurred within 5 min of incubation at 37°C and was independent 
of medium pH over the range of pH 5-8. Preincubation of cells with the lysosomotropic agent NH&l had no inhibitory 
effect on DQ. Complete inhibition was observed when target cells were fixed with glutaraldehyde prior to R-18/HIV addi- 
tion. Our results demonstrate application of membrane fluorescence dequenching method to a quantitative measurement 
of fusion between HIV and target cell membranes. As determined by DQ, HIV penetrates into target cells by a rapid, 
pH-independent, receptor-mediated and specific process of fusion between viral envelope and cell plasma membrane, 
quite similar to that observed with Sendai virus. 
HIV; Fluorescence dequenching; Membrane fusion; Target cell membrane 
1. INTRODUCTION 
Human immunodeficiency virus (HIV), the 
primary etiological agent of the acquired im- 
munodeficiency syndrome (AIDS) [l-3], is 
characterized by a remarkable potential to induce 
fusion and lysis of CD6positive human T lym- 
phocytes [l-4]. The cytopathic effects of HIV are 
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considered to be the main cause of the immune 
defects leading to AIDS [5]. According to recent 
reports, HIV enters CD4-positive target cells via 
fusion between viral envelope and target cell mem- 
branes [6-81. Binding and penetration of infec- 
tious virus requires the presence of functional 
envelope glycoproteins, gp41 and gp120 [9, lo], 
and neutralization or mutational inactivation of 
any of these proteins also abolishes cell-to-cell fu- 
sion [11,12]. The presence of surface CD4 recep- 
tors is necessary for HIV infection and for 
HIV-mediated cell fusion and lysis [4,13]. Hence, 
the interaction between fusogenic HIV envelope 
components and target membrane (via specific 
membrane receptors), and the consequent cell fu- 
sion and lysis, may play a crucial role in determin- 
ing the cytopathogenic outcome of HIV infection. 
Preliminary results of this study were presented at the IVth In- The exact parameters of the HIV-membrane fu- 
ternational AIDS Conference, Stockholm, June 12-16, 1988 sion process have been difficult to establish 
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because of the lack of a reliable quantitative assay. 
Confusing results have been published, with some 
groups claiming that HIV penetrates by pH- 
dependent endocytosis [6], and others suggesting a
pH-independent HIV-plasma membrane fusion 
[7,8]. Recently, fluorescently labeled virions and 
fluorescence dequenching methods have been ap- 
plied to a quantitative analysis of membrane fu- 
sion occurring during penetration of various 
enveloped viruses, such as Sendai virus [14], in- 
fluenza [ 151 or vesicular stomatitis virus [ 161. The 
assay involves incorporation of a self-quenching 
dye, such as the octadecylrhodamine B-chloride 
(R-18), into intact virus particles. Intermixing (fu- 
sion) of R-18-labeled viral envelopes with target 
membranes results in relief of self-quenching 
measured as an increase in fluorescence (or de- 
quenching, DQ) (reviewed in [17]). In the present 
report, we describe the application of the mem- 
brane fluorescence dequenching method to the 
study of HIV-membrane fusion. The measurements 
of the kinetics, extent, temperature, pH depen- 
dence and host cell dependence of the HIV fusion 
reaction demonstrates that HIV, similar to para- 
myxoviruses, penetrates target cells by a receptor- 
mediated, rapid and pH-independent process of 
envelope-cell membrane fusion. 
2. MATERIALS AND METHODS 
2.1. Materials 
Octadecyhhodamine B-chloride (R-18) was obtained from 
Molecular Probes (Oregon, USA); all other chemicals were of 
analytical grade. 
2.2. Cells 
The CD4+ cell line of human T cell leukemia origin, CEM 
[18], was obtained from L. Montagnier. The CD4+ T lym- 
phoblastoid cell line carrying HTLV-I virus, HUT 102, 
subclone B2 [19] was obtained from W. Greene. MLA 144 cells, 
a CDCnegative T cell of gibbon lymphoma origin [20], were ob- 
tained from American Type Culture Collection (ATCC, 
Rockville, MD). Cells were grown as stationary cultures in 
RPM1 1640, supplemented with 5% fetal bovine serum and an- 
tibiotics. 
2.3. Propagation of HIV and SV, and preparation of 
fluorescently labeled virions 
HIV (NIT isolate) was propagated in CR10 cells as described 
previously [21]. Cell-free supernatants from virus-producer 
cultures were centrifuged at 17500 x g for 2 h at 4°C in a 
Beckman JA-10 rotor, and virus sediment was resuspended in 
20 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA, pH 7.4, and 
purified by centrifugation through a lo-60% sucrose gradient 
(18 h at 160000 x g at 4°C) as described previously [22]. 
Purified HIV was resuspended at 2 mg viral protein/ml and 
frozen in aliquots. SV was isolated from the allantoic fluid of 
fertilized chicken eggs as described [14] and kept stored at 
- 80°C. Intact virions were labeled with R-18 essentially as 
described for Sendai virus [14]. Briefly, 0.6~1 of 1 mg/ml 
ethanoic solution of R-18 were rapidly added to 35 ~1 PBS 
(150 mM NaCl and 10 mM phosphate buffer, pH 7.4) contain- 
ing 50 pg of HIV or SV. After 15 min incubation in the dark, 
virus preparations were diluted in PBS to 1.5 ml and separated 
from free dye by 15 min centrifugation in an Eppendorf cen- 
trifuge. Labeled virions (R-II/HIV or R-lI/SV) were 
resuspended in PBS to a final concentration of 0.5 mg/ml viral 
protein/ml. 
2.4. Fluorescence measurements 
R- 1 S-labeled viruses were adsorbed to target cells (2.5 tg viral 
protein/l x lo6 cells) in 100 pl RPM1 1640 for 30 min at 4”C, 
followed by washing of nonadsorbed virus and incubation at 
37°C for the designated period of time. Cells were then diluted 
to 3 ml and analyzed for fluorescence in a Perkin-Elmer LS-3B 
fluorometer (560 nm excitation, 608 nm emission). Cell suspen- 
sion in a cuvette was then supplemented with 0.1 ml Triton 
X-100 (5% stock solution) to elute R-18 from membranes as a 
measure of 100% relaxation. The background fluorescence 
value was obtained by mixing R-IS/HIV and target cells im- 
mediately before measurement, so no intermixing of R-lB/virus 
and target cell membranes could occur. Specific DQ was 
calculated as follows [17]: 
% DQ = fluorescence units of: 
I( 
(system x Triton) - system 
> 
_ 
system x Triton 
( 
(background x Triton) - background x loo 
background x Triton I 
3. RESULTS 
Addition of R-18 to sucrose gradient-purified 
HIV, under the conditions previously established 
for other enveloped animal viruses [ 171, resulted in 
self-quenching of the dye. Solubilization of 
R-18-labeled HIV with Triton X-100 led to 
lo- 1 S-fold increase in fluorescence, suggesting 
that the dye was incorporated into the viral 
envelope bilayer membrane. The R-l g-labeled HIV 
remained biologically active, as determined by in- 
fectivity tests using CDCpositive CEM cells (not 
shown). 
Incubation of R-l g-labeled HIV with 
CD6positive human T lymphoid cells CEM and 
HUT 102 resulted in membrane fluorescence de- 
quenching (i.e., increase in fluorescence signal) of 
20-25% (table 1). The extent of the DQ was 
similar to that observed under the same conditions 
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Table 1 
Interaction of fluorescently-labeled human immunodeficiency 
virus and Sendai virus with cultured cells 
System Dequenching 
(DQ) Vo) 
Expt I 
CEM + R-18/HIV, 37°C 22 
CEM + R-II/HIV, 4°C 0 
MLA 144 + R-18/HIV, 37°C 0 
MLA 144 + R-lB/HIV, 4°C 0 
HUT102 + R-II/HIV, 37°C 25 
Expt II 
CEM + R-18/HIV, 37°C 21 
GA/CEM + R-IS/HIV, 37°C 3 
CEM + NH&l + R-II/HIV, 37°C 15 
Expt III 
CEM + R-18/W, 37°C 33 
CEM + R-18/W, 4°C 1 
GA/CEM + R-18&V, 37°C 15 
Experimental conditions were as described in section 2. 
Crosslinking of CEM cell surface with glutaraldehyde 
(GA/CEM) was achieved by incubating freshly washed CEM 
cells (2 x 106/ml) in PBS containing Is/o glutaraldehyde for 
15 min at 4”C, followed by 3 washes in PBS 
during incubation of R-18-labeled Sendai virus 
with CEM cells (table 1). The DQ most probably 
resulted from a specific interaction between 
R-18/HIV and virus receptor-positive CEM or 
HUT 102 cell membranes, because no increase in 
fluorescence was observed upon addition of 
R-18/HIV to gibbon T cells MLA 144 which do 
not express surface CD4 molecules/HIV receptors 
(Volsky, D.J., unpublished). MLA 144 were also 
refractory to infection with R-18/HIV or unla- 
beled virus (not shown). The specificity of R-18/ 
HIV-membrane interaction was further demon- 
strated by using glutaraldehyde-fixed CEM cells as 
targets. As shown in table 1 (expt II), incubation of 
R-18/HIV to GA/CEM cells resulted in DQ of 
only 3%, an 85% inhibition vs the DQ value for 
unfixed CEM cells. DQ of R-18/HIV fluorescence 
could also be prevented to a large measure by 
preincubating target cells with OKT4a monoclonal 
antibody, which specifically blocks the HIV-CD4 
receptor binding site ([4], not shown). 
The degree of DQ observed following incuba- 
tion of fluorescently labeled HIV with CEM cells 
was dependent on the number of cells present in 
the incubation medium, reaching a peak value at 
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Fig.1. Quantification of HIV-target membrane fusion by 
membrane fluorescence dequenching (DQ): cell saturation 
kinetics. Experimental conditions were as described in section 2. 
Time of incubation was 30 min at 37°C. 
2 x lo6 cells/l pg R-18/HIV (fig.1). The peak 
values differed for different target cells according- 
ly with the relative expression of surface CD4 
receptors (not shown). 
Kinetic studies revealed that the interaction be- 
tween R-lS/HIV and target cell membranes, as 
measured by DQ, was rapid and temperature 
dependent (fig.2 and table 1). While only negligible 
DQ was observed during 60 min of incubation of 
R-18/HIV with CEM cells at 4”C, transfer of the 
virus-cell mixture to 37°C resulted in a rapid in- 
crease in fluorescence, reaching 50% of the max- 
imum DQ value within less than 2 min (fig.2). The 
process was essentially completed in lo- 15 min at 
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Fig.2. Quantification of HIV-target membrane fusion by 
membrane fluorescence dequenching (DQ): time kinetics and 
temperature dependence. Experimental conditions were as 
described in section 2. Open and shaded symbols designate 
incubation at 4°C and 37’C, respectively. 
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Fig.3. pH-dependence of HIV-target membrane fusion as 
determined by membrane fluorescence dequenching. 
Experimental conditions were as described in section 2, except 
that 0.16 M NaCl solution, buffered to appropriate pH with 
phosphate buffer was used instead of RPMI. Time of 
incubation: 30 min at 37°C. 
37”C, similar to time kinetics data presented for 
other enveloped fusogenic viruses [ 14,151, in- 
cluding Sendai virus used here for comparison 
(table 1, expt III). 
The experiments described above established the 
basic quantitative parameters for HIV-cell interac- 
tion as measured by DQ method (table 1, figs 1 and 
2). We then approached the controversial issue 
[7-91 of the pH dependence of HIV fusion reac- 
tion. Our result show (fig.3) that the highest in- 
crease in DQ was obtained at the pH range of 5-8 
with a peak value at pH 7.0. Preincubation of 
CEM cells with a lysosomotropic agent ammonium 
chloride (50 mM) had little effect on DQ (table 1, 
expt II). 
4. DISCUSSION 
The results presented here demonstrate the ap- 
plication of membrane fluorescence dequenching 
technique [17] to a quantitative measurement of 
the process of HIV penetration into target cells. 
Purified HIV virions can be labeled with a fluores- 
cent lipotropic dye R-18 under the conditions of 
90% fluorescence quenching and without impair- 
ment of virus infectivity. Incubation of R-18/HIV 
with target cells results in 20-25% increase in 
fluorescence. We suggest hat this increase, which 
represents a relaxation of quenched molecules in 
the viral envelope [17], reflects the actual process 
of fusion between HIV envelopes and target mem- 
branes. This conclusion is supported by the results 
showing the temperature and target cell number 
dependence of DQ, the requirement for the 
presence of specific HIV receptors, and DQ inhibi- 
tion by crosslinking of target cell surface proteins. 
Use of DQ technique allowed us to elucidate 
several characteristics of HIV-membrane fusion 
that could not be determined by previously used 
semiquantitative methods [6-81. One such feature 
is the kinetics of HIV-membrane fusion at 37°C 
which, at 2 min for the half-maximal degree of 
DQ, resembles rapid fusion kinetics of potent 
fusogenic RNA viruses such as Sendai [4] or in- 
fluenza [ 151. Another feature is the apparently 
high efficienty of HIV-membrane fusion process 
as reflected by the high degree of DQ (20-25070). 
This result indicated that a significant proportion 
of labeled HIV particles interact with target cell 
membranes. Similarity in this respect with Sendai 
virus fusion should be noted again, as is evident 
from the comparison between the two viruses 
shown in table 1. Our results also show that HIV, 
like SV and other enveloped viruses, does not fuse 
significantly with target membranes at 4°C. This 
finding is in contrast with the observation of Stein 
et al. [7] who showed electron micrographs of HIV 
particles presumably fusing with cells at 4°C. 
While this discrepancy might be due to differences 
among the HIV strains used, it is not likely to be 
so. Generally, fusion between biological mem- 
branes is favored by an increased membrane fluidi- 
ty in temperatures above 4°C [23]. Papahad- 
jopoulos et al. [24] have shown, for example, that 
fusion between phospholipid vesicles requires the 
interacting membranes to be in a fluid state, i.e., 
above the phospholipid-phase transition tem- 
parature. Similarly, fusion and infectivity (but not 
binding) of Sendai, influenza and other enveloped 
viruses are completely blocked at 4°C [14,15]. 
Hence, fusion between HIV and plasma mem- 
branes at 4°C might be an extremely rare event, 
which is undetectable by DQ but can be occa- 
sionally visualized by EM. 
Stein et al. [7] and McClure et al. [S] 
demonstrated that synthesis of proviral DNA and 
syncytium formation, following exposure to HIV, 
was not affected by inhibitors of endocytosis, and 
suggested that HIV enters target cells by a pH- 
independent fusion with plasma cell membrane. 
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Maddon et al. [6] provided evidence to the con- 
trary, favoring endocytosis as a mode of HIV 
penetration. Interpretation of results presented in 
these investigations is difficult because neither 
directly measured HIV penetration when it occurs, 
namely, within 15 min of HIV addition at 37°C 
(fig.2). The data shown here clearly demonstrate 
that HIV entry into CDCpositive cells, as 
measured by DQ, does not require low pH and oc- 
curs most efficiently at pH 7. This evidence favors 
a pH-independent HIV envelope-plasma mem- 
brane fusion as the principal mechanism of HIV 
penetration. On the other hand, HIV-membrane 
fusion also clearly occurred at acidic pH (fig.3), 
suggesting that under specific conditions (or in cer- 
tain cells) HIV may penetrate cells via the en- 
docytotic pathway. Whether or not this mode of 
virus entry may lead to a productive infection has 
not yet been determined. 
In conclusion, our data demonstrate that HIV 
may enter cells by a rapid, pH-independent, 
receptor-mediated and temperature-dependent 
process of fusion with plasma membrane. 
However, the virus can also penetrate into cells at 
pH 5, compatible with receptor-mediated en- 
docytosis. The parameters of virus-membrane fu- 
sion as determined by DQ put HIV in the same 
category of fusogenic viruses as Sendai virus. 
Studies are underway to determine functional 
similarities between HIV envelope glycoproteins 
and fusion factors of paramyxoviruses. 
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